Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 516-520, March 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranelletti, F. O.
Right arrow Articles by Tonali, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranelletti, F. O.
Right arrow Articles by Tonali, P.

Glucocorticoid-binding Components in Human Thymus Hyperplasia1

Franco O. Ranelletti2, Marco Carmignani, Stefano Iacobelli and Pietro Tonali

Departments of Histology [F. O. R.], Pharmacology [M. C.], Obstetrics and Gynaecology [S. I.], and Neurology [P. T.], Catholic University School of Medicine, 644 Via della Pineta Sacchetti, 00168 Rome, Italy

Preliminary experiments on thymocyte suspensions derived from human thymus hyperplasia indicated the presence of specific cytoplasmic receptors binding [3H]dexamethasone with high affinity and specificity. The receptor was rapidly transferred into the nuclei at 28° but not at 2°. With cell-free preparations and ion-exchange cellulose-impregnated paper filters, thymus cytosol bound [3H]dexamethasone with a dissociation constant of 4.3 x 10–9 M; the concentration of receptor sites was 9.6 x 10–14 mole/mg cytosol protein. Cytosol contained binding components that sedimented at approximately 7S and 3.6S (low ionic strength) and at 4S (high ionic strength). Competition studies showed high specificity for glucocorticoids since binding of labeled dexamethasone was inhibited in the presence of 10–6 M ß-methasone, prednisolone acetate, dexamethasone, corticosterone, cortisol, and cortisone. 17ß-Estradiol, testosterone, and dlhydrotestosterone at 10–6 M did not inhibit specific binding of [3H]dexamethasone. Thus, the dexamethasone-binding components of the human thymus hyperplasia had properties similar to those described for steroid hormone receptors present in target tissues.

1 A preliminary report of this work was presented at the Eleventh World Congress of Neurology, Amsterdam, The Netherlands, September 11 to 16, 1977 (16).

2 To whom requests for reprints should be addressed.

Received 7/20/77. Accepted 11/29/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.